Abstract:AIM:To investigate the role of bone marrow-derived endothelial progenitor cells（EPCs） in the angiogenesis of hepatocellular carcinoma（HCC）.METHODS:The bone marrow of HCC mice was reconstructed by transplanting green fluorescent protein（GFP） + bone marrow cells.The concentration of circulating EPCs was determined by colony-forming assays and fluorescence-activated cell sorting.Serum and tissue levels of vascular endothelial growth factor（VEGF） and colony-stimulating factor（CSF） were quantified by enzyme-linked immunosorbent assay.The distribution of EPCs in tumor and tumor-free tissues was detected by immunohistochemistry and real-time polymerase chain reaction.The incorporation of EPCs into hepatic vessels was examined by immunofluorescence and immunohistochemistry.The proportion of EPCs in vessels was then calculated.RESULTS:The HCC model was successful established.The flow cytometry analysis showed the mean percentage of CD133CD34 and CD133VEGFR2 double positive cells in HCC mice was 0.45% ± 0.16% and 0.20% ± 0.09% respectively.These values are much higher than in the sham-operation group（0.11% ± 0.13%,0.05% ± 0.11%,n = 9） at 14 d after modeling.At 21 d,the mean percentage of circulating CD133CD34 and CD133VEGFR2 cells is 0.23% ± 0.19%,0.25% ± 0.15% in HCC model vs 0.05% ± 0.04%,0.12% ± 0.11% in control.Compared to the transient increase observed in controls,the higher level of circulating EPCs were induced by HCC.In addition,the level of serum VEGF and CSF increased gradually in HCC,reaching its peak 14 d after modeling,then slowly decreased.Consecutive sections stained for the CD133 and CD34 antigens showed that the CD133+ and CD34+ VEGFR2 cells were mostly recruited to HCC tissue and concentrated in tumor microvessels.Under fluorescence microscopy,the bone-marrow（BM）-derived cells labeled with GFP were concentrated in the same area.The relative levels of CD133 and CD34 gene expression were elevated in tumors,around 5.0 and 3.8 times that of the tumor free area.In frozen liver sections from HCC mice,cells co-expressing CD133 and VEGFR2 were identified by immunohistochemical staining using anti-CD133 and VEGFR2 antibodies.In tumor tissue,the double-positive cells were incorporated into vessel walls.In immunofluorescent staining.These CD31 and GFP double positive cells are direct evidence that tumor vascular endothelial cells（VECs） come partly from BM-derived EPCs.The proportion of GFP CD31 double positive VECs（out of all VECs） on day 21 was around 35.3% ± 21.2%.This is much higher than the value recorded on day 7 group（17.1% ± 8.9%）.The expression of intercellular adhesion molecule 1,vascular adhesion molecule 1,and VEGF was higher in tumor areas than in tumor-free tissues.CONCLUSION:Mobilized EPCs were found to participate in tumor vasculogenesis of HCC.Inhibiting EPC mobilization or recruitment to tumor tissue may be an efficient strategy for treating HCC.

Experimental Study on Endothelial Progenitor Cells for Angiogenesis of Lung Cancer Tube

In Vitro and in Vivo Angiogenic Capacity Analysis on Different Clonal Endothelial Progenitor Cell Populations Derived from Human Circulating Blood

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Primary Culture,identification and in Vitro Angiogenesis of Mouse Pulmonary Microvascular Endothelial Cells

Transplantation of Endothelial Progenitor Cells from Peripheral Blood Enhancing Neovascularization in Ischemic Tissue of Nude Mice

Effect of Transplantation of Bone Marrow Mesenchymal Stem Cells Genetically Modified with Human Hepatocyte Growth Factor Gene on Angiogenesis in Rat Lung

Comparison of Revascularization of Bone Marrow Mononuclear Cells and Endothelial Progenitor Cells Transplantation

Effect of bevacizumab on angiogenesis and related cytokines in mice with malignant pleural effusion

Transplantation of Autologous Angiogenin-Overexpressing Marrow Stromal Cells in Treatment of a Porcine Chronic Ischemia Model

The experimental study of ginsenoside Rg3 inhibiting angiogenesis induced by tumor cells

A Novel Tissue Model for Angiogenesis: Evaluation of Inhibitors or Promoters in Tissue Level

[Biological Effect of Endostatin on Transplanted Human Lung Adenocarcinoma Calu-6 Tumor in Nude Mice].

Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro

The Effect of Interferon-β on Endothelial Progenitor Cell-induced Tumor Angiogenesis

Endothelial Precursor Cells Promote Angiogenesis in Hepatocellular Carcinoma

Effect of angiostatin gene on growth and metastasis of pancreatic carcinoma strain PC-3 orthotopic implantation model in mice

Bronchial Artery Angiogenesis Drives Lung Tumor Growth

Effects of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation on Vein Microenvironment in a Rat Model of Chronic Thrombosis.

The Effect That Angiostatin Inhibits Growth of Transplanted Tumor of Oral Squamous-Cell Carcinoma

Isolation,Purification and Identification of Pancreatic Cancer Endothelial Cells